Company: CERO
Filing Date: 2025-04-01
Form Type: NT 10-K
Source: 0001213900-25-026702
Chunk: 4

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-01
Form: NT 10-K
Chunk 4
---
 those discussed under Part I, Item 1A. “Risk Factors” contained in the Registrant’s most
recent Annual Report on Form 10-K, and Part II, Item 1A. “Risk Factors” contained in the Registrant’s subsequent Quarterly
Reports on Form 10-Q, as well as any amendments thereto.

The Registrant’s forward-looking statements
contained in this document are based on the beliefs, expectations, and opinions of management as of the date of this document. The Registrant
does not assume any obligation to update forward-looking statements if circumstances or management’s beliefs, expectations, or opinions
should change, except as required by law. For the reasons set forth above, investors should not attribute undue certainty to, or place
undue reliance on, forward-looking statements.

<div align='center'>CERo Therapeutics Holdings, Inc.

(Name of Registrant as Specified in Charter)</div>

has caused this notification to be signed on its behalf
by the undersigned hereunto duly authorized.

| Date: April 1, 2025 | By: | /s/ Chris Ehrlich |                         |
|:--------------------|:----|:------------------|:------------------------|
|                     |     | Name:             | Chris Ehrlich           |
|                     |     | Title:            | Chief Executive Officer |